- Home
- MIRA vs GRF Comparison
MIRA vs GRF Comparison
Compare MIRA & GRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MIRA | GRF |
|---|---|---|
| Founded | 2020 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.7M | 39.9M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | MIRA | GRF |
|---|---|---|
| Price | $0.98 | $10.24 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 61.8K | 2.3K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.70% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.16 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.82 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.90 | $9.60 |
| 52 Week High | $2.45 | $11.85 |
Technical Indicators
Market Signals| Indicator | MIRA | GRF |
|---|---|---|
| Relative Strength Index (RSI) | 53.01 | 55.32 |
| Support Level | $0.91 | $9.96 |
| Resistance Level | $1.01 | $10.29 |
| Average True Range (ATR) | 0.05 | 0.06 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 55.95 | 82.81 |
Price Performance
Historical ComparisonAbout MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.
About GRF Eagle Capital Growth Fund Inc.
Eagle Capital Growth Fund Inc is a diversified closed-end investment company. The Fund's objective is long-term growth utilizing the concept of total return for selecting investments. It seeks to achieve its investment objectives by investing predominantly in U.S. issuer common stock, giving preference to high-quality companies, where high quality denotes substantial operating income margins, high returns on capital, and robust balance sheets.